Report Detail

Other Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2019-2025

  • RnM3674278
  • |
  • 16 August, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adulthood.
Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.
In 2018, the global Lennox-Gastaut Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lennox-Gastaut Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lennox-Gastaut Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Eisai Co., Ltd.
GlaxoSmithKline plc.
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
Supernus Pharmaceuticals, Inc
...

Market segment by Type, the product can be split into
Non-surgical Treatment
Surgical Treatment

Market segment by Application, split into
Seizures
Ocular Abnormality
EEG Findings
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lennox-Gastaut Syndrome Treatment status, future forecast, growth opportunity, key market and key players.
To present the Lennox-Gastaut Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lennox-Gastaut Syndrome Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Lennox-Gastaut Syndrome Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Non-surgical Treatment
      • 1.4.3 Surgical Treatment
    • 1.5 Market by Application
      • 1.5.1 Global Lennox-Gastaut Syndrome Treatment Market Share by Application (2019-2025)
      • 1.5.2 Seizures
      • 1.5.3 Ocular Abnormality
      • 1.5.4 EEG Findings
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Lennox-Gastaut Syndrome Treatment Market Size
    • 2.2 Lennox-Gastaut Syndrome Treatment Growth Trends by Regions
      • 2.2.1 Lennox-Gastaut Syndrome Treatment Market Size by Regions (2019-2025)
      • 2.2.2 Lennox-Gastaut Syndrome Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Lennox-Gastaut Syndrome Treatment Market Size by by Players
      • 3.1.1 Global Lennox-Gastaut Syndrome Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Lennox-Gastaut Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Lennox-Gastaut Syndrome Treatment Key Players Head office and Area Served
    • 3.3 Key Players Lennox-Gastaut Syndrome Treatment Product/Solution/Service
    • 3.4 Date of Enter into Lennox-Gastaut Syndrome Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Lennox-Gastaut Syndrome Treatment Market Size by Type (2014-2019)
    • 4.2 Global Lennox-Gastaut Syndrome Treatment Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
    • 5.2 Lennox-Gastaut Syndrome Treatment Key Players in North America
    • 5.3 North America Lennox-Gastaut Syndrome Treatment Market Size by Type
    • 5.4 North America Lennox-Gastaut Syndrome Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
    • 6.2 Lennox-Gastaut Syndrome Treatment Key Players in Europe
    • 6.3 Europe Lennox-Gastaut Syndrome Treatment Market Size by Type
    • 6.4 Europe Lennox-Gastaut Syndrome Treatment Market Size by Application

    7 China

    • 7.1 China Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
    • 7.2 Lennox-Gastaut Syndrome Treatment Key Players in China
    • 7.3 China Lennox-Gastaut Syndrome Treatment Market Size by Type
    • 7.4 China Lennox-Gastaut Syndrome Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
    • 8.2 Lennox-Gastaut Syndrome Treatment Key Players in Japan
    • 8.3 Japan Lennox-Gastaut Syndrome Treatment Market Size by Type
    • 8.4 Japan Lennox-Gastaut Syndrome Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
    • 9.2 Lennox-Gastaut Syndrome Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Type
    • 9.4 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Application

    10 India

    • 10.1 India Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
    • 10.2 Lennox-Gastaut Syndrome Treatment Key Players in India
    • 10.3 India Lennox-Gastaut Syndrome Treatment Market Size by Type
    • 10.4 India Lennox-Gastaut Syndrome Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
    • 11.2 Lennox-Gastaut Syndrome Treatment Key Players in Central & South America
    • 11.3 Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Type
    • 11.4 Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Eisai Co., Ltd.
      • 12.1.1 Eisai Co., Ltd. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Lennox-Gastaut Syndrome Treatment Introduction
      • 12.1.4 Eisai Co., Ltd. Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019))
      • 12.1.5 Eisai Co., Ltd. Recent Development
    • 12.2 GlaxoSmithKline plc.
      • 12.2.1 GlaxoSmithKline plc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Lennox-Gastaut Syndrome Treatment Introduction
      • 12.2.4 GlaxoSmithKline plc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
      • 12.2.5 GlaxoSmithKline plc. Recent Development
    • 12.3 H. Lundbeck A/S
      • 12.3.1 H. Lundbeck A/S Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Lennox-Gastaut Syndrome Treatment Introduction
      • 12.3.4 H. Lundbeck A/S Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
      • 12.3.5 H. Lundbeck A/S Recent Development
    • 12.4 Johnson & Johnson Services, Inc.
      • 12.4.1 Johnson & Johnson Services, Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Lennox-Gastaut Syndrome Treatment Introduction
      • 12.4.4 Johnson & Johnson Services, Inc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
      • 12.4.5 Johnson & Johnson Services, Inc. Recent Development
    • 12.5 Supernus Pharmaceuticals, Inc
      • 12.5.1 Supernus Pharmaceuticals, Inc Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Lennox-Gastaut Syndrome Treatment Introduction
      • 12.5.4 Supernus Pharmaceuticals, Inc Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
      • 12.5.5 Supernus Pharmaceuticals, Inc Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Lennox-Gastaut Syndrome Treatment. Industry analysis & Market Report on Lennox-Gastaut Syndrome Treatment is a syndicated market report, published as Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Lennox-Gastaut Syndrome Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,120.00
      4,680.00
      6,240.00
      3,630.90
      5,446.35
      7,261.80
      606,099.00
      909,148.50
      1,212,198.00
      325,650.00
      488,475.00
      651,300.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report